Deputy Chief Medical Officer Dr John Burke explains our process for authorising treatments.
In this archive we aim to publish our commissioned reviews into the clinical evidence available for selected treatments, alongside our decision on whether we will authorise these treatments.
Review #3: are high-intensity focused ultrasound (HIFU), irreversible electroporation (IRE) and cryotherapy recommended treatments in prostate cancer? Conclusion: amber/not authorised.Download prostate cancer treatments review here
Review #7: what is the evidence for hyperthermic intraoperative peritoneal chemotherapy (HIPEC) in the prevention of peritoneal carcinomatosis in patients with colorectal cancer? Conclusion: amber/not authorised.Download HIPEC review here